Curis
CRIS
#10292
Rank
NZ$18.69 M
Marketcap
NZ$1.45
Share price
-2.90%
Change (1 day)
-76.92%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2025 (TTM): -NZ$56.22 Million

According to Curis's latest financial reports the company's current earnings are NZ$11.65 Million. In 2024 the company made an earning of -NZ$70.95 Million, an increase over its 2023 earnings that were of -NZ$75.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$56.22 Million-20.76%
2024 -NZ$70.95 Million-5.77%
2023 -NZ$75.3 Million-13.1%
2022 -NZ$86.64 Million27.52%
2021 -NZ$67.95 Million65.09%
2020 -NZ$41.16 Million-9.1%
2019 -NZ$45.28 Million-4.73%
2018 -NZ$47.52 Million-41.95%
2017 -NZ$81.86 Million-14.37%
2016 -NZ$95.6 Million3.55%
2015 -NZ$92.32 Million271.52%
2014 -NZ$24.85 Million76.64%
2013 -NZ$14.07 Million
2011 -NZ$11.95 Million27.76%
2010 -NZ$9.36 Million-43.87%
2009 -NZ$16.67 Million-23.44%
2008 -NZ$21.77 Million56.66%
2007 -NZ$13.9 Million-16.71%
2006 -NZ$16.68 Million-36.92%
2005 -NZ$26.44 Million156.25%
2004 -NZ$10.32 Million-37.24%
2003 -NZ$16.45 Million-93.34%
2002 -NZ$0.25 Billion86.79%
2001 -NZ$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$19.65 B-36,502.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.32 B-24,772.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.11 Billion 90.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.44 B-2,782.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.43 Billion 687.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$41.08 Million-23.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.27 B-607.71%๐Ÿ‡บ๐Ÿ‡ธ USA